Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

HARROW HEALTH, INC. (IMMY) > Segments

Pharmaceutical Compounding

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   72.548.951.2    
            Revenue growth   48.3%-4.5%     
Gross profit   54.334.434.4    
            Gross margin   74.9%70.4%67.3%    
Selling, general and administrative   27.522.724.5    
Research and development   1.10.81.0    
EBIT   25.711.08.9    
            EBIT margin   35.5%22.4%17.5%    
   
Revenue Mix   100.0%100.0%100.0%    
EBIT Mix   1592.9%2846.2%     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy